Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation
about
Efficacy of Carraguard-based microbicides in vivo despite variable in vitro activityHIV-1 cell to cell transfer across an Env-induced, actin-dependent synapseHIV Genome-Wide Protein Associations: a Review of 30 Years of ResearchHepatitis C Virus-Like Particle Budding: Role of the Core Protein and Importance of Its Asp111Functional properties of the HIV-1 subtype C envelope glycoprotein associated with mother-to-child transmissionAmino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses.Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R Peptide.Mutagenesis of tyrosine and di-leucine motifs in the HIV-1 envelope cytoplasmic domain results in a loss of Env-mediated fusion and infectivity.HIV-1 envelope glycoprotein biosynthesis, trafficking, and incorporation.Systematic analysis of intracellular trafficking motifs located within the cytoplasmic domain of simian immunodeficiency virus glycoprotein gp41The membrane-proximal tyrosine-based sorting signal of human immunodeficiency virus type 1 gp41 is required for optimal viral infectivity.Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.A tyrosine-based motif in the HIV-1 envelope glycoprotein tail mediates cell-type- and Rab11-FIP1C-dependent incorporation into virions.A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particlesHost factors influencing susceptibility to HIV infection and AIDS progression.Functional diversity of HIV-1 envelope proteins expressed by contemporaneous plasma virusesTruncation of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein defines elements required for fusion, incorporation, and infectivityRelationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.Surface stability and immunogenicity of the human immunodeficiency virus envelope glycoprotein: role of the cytoplasmic domain.Hidden messages in the nef gene of human immunodeficiency virus type 1 suggest a novel RNA secondary structure.Antagonism to and intracellular sequestration of human tetherin by the human immunodeficiency virus type 2 envelope glycoprotein.New Connections: Cell-to-Cell HIV-1 Transmission, Resistance to Broadly Neutralizing Antibodies, and an Envelope Sorting Motif.Endocytosis of the Nipah virus glycoproteinsModulation of Env content in virions of simian immunodeficiency virus: correlation with cell surface expression and virion infectivity.Anti-human immunodeficiency virus type 1 (HIV-1) antibodies 2F5 and 4E10 require surprisingly few crucial residues in the membrane-proximal external region of glycoprotein gp41 to neutralize HIV-1.Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail.Mutation of critical serine residues in HIV-1 matrix result in an envelope incorporation defect which can be rescued by truncation of the gp41 cytoplasmic tail.Differential functional phenotypes of two primary HIV-1 strains resulting from homologous point mutations in the LLP domains of the envelope gp41 intracytoplasmic domain.
P2860
Q21562543-39D16484-2D04-42CB-BCE7-75274EF53388Q22242967-97D82D2F-DEB0-44FA-8E49-F4174A1F56C0Q26746070-3891BB9E-29FE-411D-8C45-B623509699F0Q27485400-BA185426-D1A8-4793-A8E5-5766887FD2FBQ33749206-E184CD9F-3755-4093-A5ED-C082D1224F26Q33987373-FA2964A9-B902-476F-B501-14553770A2A8Q34306883-C4D50F18-F437-43B7-9B40-65465BFD3C3DQ34434813-1727590F-0A2E-429D-9198-AB0C4F615317Q34439347-8F98BB2D-5784-47E7-88D3-16EF935C5D3EQ34464572-E0450186-5E2C-46F8-A6D0-13DFAB9FE638Q35052938-ADBDEB22-D2D2-4C65-8510-901BA59D5BAEQ35113720-2E670194-49F0-4D27-AE78-FB8D372F83AAQ35494155-9D812E82-C727-4770-9AC8-7E56599166AFQ35542648-C201DC8A-19A6-4321-BF13-45FD3D491CC2Q35634348-E0F8254A-3CF6-48A2-8E2F-B28946F0E5B3Q35764347-47990840-2382-4BB4-9063-9BAAFA4C1461Q35826475-F7E85041-2CB0-445C-9F12-9D17637A64E2Q35995936-3B183509-6D8D-409B-89DB-D9EE38297E95Q36502557-C3B02631-F081-4A6E-8A39-1382255E5966Q37410656-E2A6EF39-5F4A-46CB-9CB8-F1E95F85A9AFQ37568313-2C023068-B7C8-4829-897E-24624E846D75Q37683010-6F31C5F0-31CC-4FBD-A256-E7ACBFC1AE28Q39792146-4B666960-4F9D-490A-AF4C-A1FF8DF98A36Q39801517-341DA839-9B83-4F64-AA1A-3BA38EBC5454Q40312301-6F6CBDEA-7ACF-4C8E-8055-F7BA6E892089Q40454342-FB7BC613-C20E-4C24-88C3-2E5D8B41446EQ40546009-7E4CA043-7EEF-4067-90FE-0C2C341DC65DQ40721814-33C8C2F4-CC42-4190-A8B6-BCAA72DCB651Q41898146-2996CD8A-25B2-4FC1-9E34-712BFDEDC308Q43168272-416A0F10-F2FC-441F-855E-C17683DA0359Q55508034-777F6CE9-B9DE-4FCC-B7A7-7499702B9671
P2860
Mutation of the dominant endocytosis motif in human immunodeficiency virus type 1 gp41 can complement matrix mutations without increasing Env incorporation
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Mutation of the dominant endoc ...... t increasing Env incorporation
@ast
Mutation of the dominant endoc ...... t increasing Env incorporation
@en
Mutation of the dominant endoc ...... t increasing Env incorporation
@nl
type
label
Mutation of the dominant endoc ...... t increasing Env incorporation
@ast
Mutation of the dominant endoc ...... t increasing Env incorporation
@en
Mutation of the dominant endoc ...... t increasing Env incorporation
@nl
prefLabel
Mutation of the dominant endoc ...... t increasing Env incorporation
@ast
Mutation of the dominant endoc ...... t increasing Env incorporation
@en
Mutation of the dominant endoc ...... t increasing Env incorporation
@nl
P2093
P2860
P1433
P1476
Mutation of the dominant endoc ...... t increasing Env incorporation
@en
P2093
Eric Hunter
John T West
Markus Thali
Sally K Weldon
Stephanie Wyss
Xiaoxu Lin
P2860
P304
P356
10.1128/JVI.76.7.3338-3349.2002
P407
P577
2002-04-01T00:00:00Z